Anne-Virginie joined bluebird bio in September 2011 to lead the Regulatory Science function. Prior to joining bluebird bio, Anne-Virginie was an Executive Director at Voisin Consulting, leading projects involving the design and implantation of regulatory strategies for medicinal products, with a particular focus on rare diseases including oncology, and advanced therapies. Her experience spans from early development through commercialization including lead roles on the registration of several orphan drugs and regulatory expertise on both sides of the Atlantic. Anne-Virginie holds a Master of Science in Environmental Health Sciences from the UCLA School of Public Health, as well as a B.S. in Chemical Engineering from the California Institute of Technology.
1:45 PM–2:45 PM Jun 5, 2018 (US - Eastern)